Translation through collaboration: practice applied in BAMOS project in in vivo testing of innovative osteochondral scaffolds.

Ricardo Donate, Maryam Tamaddon, Viviana Ribeiro, Mario Monzón, J Miguel Oliveira, Chaozong Liu, Mm, Mm, Cl, Jmo, Rd, Mm, Rd, Mt, Vr, Cl, Jmo
{"title":"Translation through collaboration: practice applied in BAMOS project in <i>in vivo</i> testing of innovative osteochondral scaffolds.","authors":"Ricardo Donate,&nbsp;Maryam Tamaddon,&nbsp;Viviana Ribeiro,&nbsp;Mario Monzón,&nbsp;J Miguel Oliveira,&nbsp;Chaozong Liu,&nbsp;Mm,&nbsp;Mm,&nbsp;Cl,&nbsp;Jmo,&nbsp;Rd,&nbsp;Mm,&nbsp;Rd,&nbsp;Mt,&nbsp;Vr,&nbsp;Cl,&nbsp;Jmo","doi":"10.12336/biomatertransl.2022.02.003","DOIUrl":null,"url":null,"abstract":"<p><p>Osteoarthritis is the most common chronic degenerative joint disease, recognized by the World Health Organization as a public health problem that affects millions of people worldwide. The project Biomaterials and Additive Manufacturing: Osteochondral Scaffold (BAMOS) innovation applied to osteoarthritis, funded under the frame of the Horizon 2020 Research and Innovation Staff Exchanges (RISE) program, aims to delay or avoid the use of joint replacements by developing novel cost-effective osteochondral scaffold technology for early intervention of osteoarthritis. The multidisciplinary consortium of BAMOS, formed by international leading research centres, collaborates through research and innovation staff exchanges. The project covers all the stages of the development before the clinical trials: design of scaffolds, biomaterials development, processability under additive manufacturing, in vitro test, and in vivo test. This paper reports the translational practice adopted in the project in in vivo assessment of the osteochondral scaffolds developed.</p>","PeriodicalId":58820,"journal":{"name":"Biomaterials Translational","volume":"3 2","pages":"102-104"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2f/c8/bt-03-02-102.PMC9465993.pdf","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomaterials Translational","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12336/biomatertransl.2022.02.003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

Osteoarthritis is the most common chronic degenerative joint disease, recognized by the World Health Organization as a public health problem that affects millions of people worldwide. The project Biomaterials and Additive Manufacturing: Osteochondral Scaffold (BAMOS) innovation applied to osteoarthritis, funded under the frame of the Horizon 2020 Research and Innovation Staff Exchanges (RISE) program, aims to delay or avoid the use of joint replacements by developing novel cost-effective osteochondral scaffold technology for early intervention of osteoarthritis. The multidisciplinary consortium of BAMOS, formed by international leading research centres, collaborates through research and innovation staff exchanges. The project covers all the stages of the development before the clinical trials: design of scaffolds, biomaterials development, processability under additive manufacturing, in vitro test, and in vivo test. This paper reports the translational practice adopted in the project in in vivo assessment of the osteochondral scaffolds developed.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
合作转化:BAMOS项目在创新骨软骨支架体内测试中的实践应用。
骨关节炎是最常见的慢性退行性关节疾病,被世界卫生组织认定为影响全球数百万人的公共卫生问题。“生物材料和增材制造:骨软骨支架(BAMOS)创新应用于骨关节炎”项目是在“地平线2020”研究与创新人员交流(RISE)计划框架下资助的,旨在通过开发具有成本效益的新型骨软骨支架技术来延缓或避免使用关节置换术,用于骨关节炎的早期干预。BAMOS的多学科联盟由国际领先的研究中心组成,通过研究和创新人员交流进行合作。该项目涵盖了临床试验前的所有开发阶段:支架的设计、生物材料的开发、增材制造的可加工性、体外测试和体内测试。本文报道了所研制的骨软骨支架在体内评估项目中采用的转化实践。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.70
自引率
0.00%
发文量
9
期刊最新文献
"Yin-Yang philosophy" for the design of anticancer drug delivery nanoparticles. Abalone shell-derived Mg-doped mesoporous hydroxyapatite microsphere drug delivery system loaded with icariin for inducing apoptosis of osteosarcoma cells. Advanced nanoparticles in osteoarthritis treatment. Artificial intelligence-enabled studies on organoid and organoid extracellular vesicles. Corrigendum: Enhanced angiogenesis in porous poly(ε-caprolactone) scaffolds fortified with methacrylated hyaluronic acid hydrogel after subcutaneous transplantation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1